Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1043]

Risks of novel oral prostate cancer therapies and pre-existing conditions

Risks of novel oral prostate cancer therapies and pre-existing conditions

ASCO 2019: The eight biggest stories on anticancer agents

ASCO 2019: The eight biggest stories on anticancer agents

AI reveals new breast cancer types that respond differently to treatment

AI reveals new breast cancer types that respond differently to treatment

FDA approves darolutamide for non-metastatic castration-resistant prostate cancer

FDA approves darolutamide for non-metastatic castration-resistant prostate cancer

Abemaciclib significantly extended life in women with hormone receptor-positive, HER2-negative advanced breast cancer

Abemaciclib significantly extended life in women with hormone receptor-positive, HER2-negative advanced breast...

Discovery shows how difficult-to-treat prostate cancer evades immune system

Discovery shows how difficult-to-treat prostate cancer evades immune system

FDA approves daratumumab for multiple myeloma patients ineligible for autologous stem cell transplant

FDA approves daratumumab for multiple myeloma patients ineligible for autologous stem cell transplant

Healthcare guidelines should be updated for patients with certain adrenal tumours

Healthcare guidelines should be updated for patients with certain adrenal tumours

Unhealthy gut promotes spread of breast cancer, study finds

Unhealthy gut promotes spread of breast cancer, study finds

ASCO 2019: New TAILORx data guides adjuvant therapy in younger breast cancer patients

ASCO 2019: New TAILORx data guides adjuvant therapy in younger breast cancer patients

More from ecancer